Riyadh: CEO of the Saudi Food and Drug Authority (SFDA) Dr. Hisham Aljadhey launched the 'Saudi Pharmacopoeia' on the sidelines of the SFDA's participation in the Global Health Exhibition held at the Riyadh Exhibition and Convention Center in Malham from October 27 to 30, under the theme 'Invest in Health.'
According to Saudi Press Agency, Aljadhey stated that the Saudi Pharmacopoeia marks a new phase that affirms the Kingdom of Saudi Arabia's global leadership in this vital field. This initiative is backed by a laboratory infrastructure that enhances the compliance of pharmaceutical products registered in the Kingdom with the highest standards of quality, efficacy, and safety. The Pharmacopoeia includes specialized chapters, notably the "Halal" chapter, setting a regulatory precedent among global pharmacopoeias and reflecting the Kingdom's efforts in adopting regulatory standards compatible with Islamic Sharia, contributing to enhancing the confidence of regional and international markets.
Aljadhey emphasized that the SFDA is spearheading this national project based on its pivotal role in developing the drug regulatory system, showcasing the Kingdom's global position in the field of medicine. He noted that the Pharmacopoeia significantly supports the growth of the national pharmaceutical industry and plays an effective role in achieving compatibility with international regulations while considering local needs, aligning with the objectives of the Health Sector Transformation Program, part of the Saudi Vision 2030 programs.
The Saudi Pharmacopoeia enhances the competitiveness of local manufacturers, serves as an important attraction factor for foreign investment in the Saudi market, and provides a clear basis for quality and testing requirements. This effort facilitates regulatory compliance, supports localization programs and human capacity building, increases consumer confidence in marketed products, and enables Saudi pharmaceuticals to compete globally.
The press release added that the Pharmacopoeia serves as an official reference for determining quality specifications and standards for medicines and vaccines, including their formulation and methods of analysis. It serves as a scientific basis used by regulatory bodies, pharmaceutical companies, and laboratories to enhance drug safety and quality. It also contributes to the growth of research and innovation.
The Global Health Forum is a leading platform for innovation in healthcare, bringing together prominent leaders and influencers in the health sector. It aims to enhance healthcare and create innovative solutions that positively impact global health systems.